No Data
Koseido: First Quarter Report 2025
Koseido: 2024 Annual Report
Koseido: 2024 Annual Report Summary
Fujian Cosunter Pharmaceutical Co., Ltd.'s (SZSE:300436) 30% Share Price Plunge Could Signal Some Risk
Brokerage morning meeting highlights: The USA has increased tariffs on China, but the impact on these industries in the A-shares may be limited.
In today's brokerage morning meeting, GF SEC believes that the USA's tariffs on China have a limited impact on the A-share Computer Industry; China Securities Co.,Ltd. suggested being Bullish on the Innovative Drugs industry that is currently not affected by tariffs; Galaxy Securities stated that Deep Sea Technology has entered a new stage in Global Strategy, focusing on opportunities in core equipment.
Cosunter Pharmaceutical to Raise 977 Million Yuan From Planned Share Issuance; Shares Down 4%
Fujian Cosunter Pharmaceutical Co., Ltd.'s (SZSE:300436) Popularity With Investors Under Threat As Stock Sinks 25%